These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12573031)

  • 1. Stability of recombinant protein production in the GS-NS0 expression system is unaffected by cryopreservation.
    Barnes LM; Bentley CM; Dickson AJ
    Biotechnol Prog; 2003; 19(1):233-7. PubMed ID: 12573031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of protein production from recombinant mammalian cells.
    Barnes LM; Bentley CM; Dickson AJ
    Biotechnol Bioeng; 2003 Mar; 81(6):631-9. PubMed ID: 12529877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of hyperosmotic pressure on antibody production and gene expression in the GS-NS0 cell line.
    Wu MH; Dimopoulos G; Mantalaris A; Varley J
    Biotechnol Appl Biochem; 2004 Aug; 40(Pt 1):41-6. PubMed ID: 15270706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivation and characterization of cholesterol-independent non-GS NS0 cell lines for production of recombinant antibodies.
    Hartman TE; Sar N; Genereux K; Barritt DS; He Y; Burky JE; Wesson MC; Tso JY; Tsurushita N; Zhou W; Sauer PW
    Biotechnol Bioeng; 2007 Feb; 96(2):294-306. PubMed ID: 16897745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of successful cell line selection in transfected GS-NS0 myeloma cells.
    Barnes LM; Bentley CM; Moy N; Dickson AJ
    Biotechnol Bioeng; 2007 Feb; 96(2):337-48. PubMed ID: 17001634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular definition of predictive indicators of stable protein expression in recombinant NS0 myeloma cells.
    Barnes LM; Bentley CM; Dickson AJ
    Biotechnol Bioeng; 2004 Jan; 85(2):115-21. PubMed ID: 14704993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional proteomic analysis of GS-NS0 murine myeloma cell lines with varying recombinant monoclonal antibody production rate.
    Dinnis DM; Stansfield SH; Schlatter S; Smales CM; Alete D; Birch JR; Racher AJ; Marshall CT; Nielsen LK; James DC
    Biotechnol Bioeng; 2006 Aug; 94(5):830-41. PubMed ID: 16489627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular portrait of high productivity in recombinant NS0 cells.
    Seth G; Philp RJ; Lau A; Jiun KY; Yap M; Hu WS
    Biotechnol Bioeng; 2007 Jul; 97(4):933-51. PubMed ID: 17149768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A genome-wide transcriptional analysis of producer and non-producer NS0 myeloma cell lines.
    Khoo SH; Falciani F; Al-Rubeai M
    Biotechnol Appl Biochem; 2007 Jun; 47(Pt 2):85-95. PubMed ID: 17223793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced growth in NS0 cells expressing aminoglycoside phosphotransferase is associated with changes in metabolism, productivity, and apoptosis.
    Veraitch FS; Al-Rubeai M
    Biotechnol Bioeng; 2005 Dec; 92(5):589-99. PubMed ID: 16267848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of cell cycle for enhancement of antibody productivity in perfusion culture of NS0 cells.
    Ibarra N; Watanabe S; Bi JX; Shuttleworth J; Al-Rubeai M
    Biotechnol Prog; 2003; 19(1):224-8. PubMed ID: 12573029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic analysis of GS-NS0 cells producing a recombinant monoclonal antibody during fed-batch culture.
    Stansfield SH; Allen EE; Dinnis DM; Racher AJ; Birch JR; James DC
    Biotechnol Bioeng; 2007 Jun; 97(2):410-24. PubMed ID: 17115445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved fermentation processes for NS0 cell lines expressing human antibodies and glutamine synthetase.
    Dempsey J; Ruddock S; Osborne M; Ridley A; Sturt S; Field R
    Biotechnol Prog; 2003; 19(1):175-8. PubMed ID: 12573022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of a mammalian cell culture process by adaptive, model-based dialysis fed-batch cultivation and suppression of apoptosis.
    Frahm B; Lane P; Märkl H; Pörtner R
    Bioprocess Biosyst Eng; 2003 Nov; 26(1):1-10. PubMed ID: 14505167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of an artificially selected GS-NS0 variant with increased resistance to apoptosis.
    Browne SM; Al-Rubeai M
    Biotechnol Bioeng; 2011 Apr; 108(4):880-92. PubMed ID: 21404261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and analysis of a mathematical model for antibody-producing GS-NS0 cells under normal and hyperosmotic culture conditions.
    Ho Y; Varley J; Mantalaris A
    Biotechnol Prog; 2006; 22(6):1560-9. PubMed ID: 17137302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of flow-cytometric analysis to optimize cell banking strategies for production of biopharmaceuticals from mammalian cells.
    Fieder J; Wagner N; Grammatikos S; Hoffmann H; Kaufmann H; Otto RT
    J Biotechnol; 2005 Oct; 120(1):111-20. PubMed ID: 16043250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis of enriched microsomal fractions from GS-NS0 murine myeloma cells with varying secreted recombinant monoclonal antibody productivities.
    Alete DE; Racher AJ; Birch JR; Stansfield SH; James DC; Smales CM
    Proteomics; 2005 Dec; 5(18):4689-704. PubMed ID: 16247733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large-scale gene expression analysis of cholesterol dependence in NS0 cells.
    Seth G; Philp RJ; Denoya CD; McGrath K; Stutzman-Engwall KJ; Yap M; Hu WS
    Biotechnol Bioeng; 2005 Jun; 90(5):552-67. PubMed ID: 15830340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Metabolic characteristics of GS-nS0 myeloma cells producing anti-CD25 monoclonal antibody in serum-free culture].
    Zhao L; Fan L; Zhang X; Tan W
    Sheng Wu Gong Cheng Xue Bao; 2009 Jul; 25(7):1069-76. PubMed ID: 19835150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.